ABS0812 COMPARISON OF THE CLINICAL EFFECTS OF JAK INHIBITORS AND IL-6 INHIBITORS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS Article Swipe

View

K. Mamoto , Tadashi Okano , Y. Yamada , Toshihisa Kojima , S. Anno , Kumi Orita , Tetsuo Iida , M. Tada , Kentaro Inui , Tatsuya Koike , Hidetomi Terai ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1016/j.ard.2025.06.1600

Related Topics

Concepts

Medicine Rheumatoid arthritis Internal medicine Arthritis Immunology Tocilizumab

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1016/j.ard.2025.06.1600
OA Status: hybrid
Related Works: 10
OpenAlex ID: https://openalex.org/W4411400243

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4411400243

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1016/j.ard.2025.06.1600

Digital Object Identifier
Title: ABS0812 COMPARISON OF THE CLINICAL EFFECTS OF JAK INHIBITORS AND IL-6 INHIBITORS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-06-01

Full publication date if available
Authors: K. Mamoto, Tadashi Okano, Y. Yamada, Toshihisa Kojima, S. Anno, Kumi Orita, Tetsuo Iida, M. Tada, Kentaro Inui, Tatsuya Koike, Hidetomi Terai

List of authors in order
Landing page: https://doi.org/10.1016/j.ard.2025.06.1600

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: hybrid

Open access status per OpenAlex
OA URL: https://doi.org/10.1016/j.ard.2025.06.1600

Direct OA link when available
Concepts: Medicine, Rheumatoid arthritis, Internal medicine, Arthritis, Immunology, Tocilizumab

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4411400243
doi	https://doi.org/10.1016/j.ard.2025.06.1600
ids.doi	https://doi.org/10.1016/j.ard.2025.06.1600
ids.openalex	https://openalex.org/W4411400243
fwci	0.0
type	article
title	ABS0812 COMPARISON OF THE CLINICAL EFFECTS OF JAK INHIBITORS AND IL-6 INHIBITORS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
biblio.issue
biblio.volume	84
biblio.last_page	2022
biblio.first_page	2021
topics[0].id	https://openalex.org/T11503
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9894999861717224
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2730
topics[0].subfield.display_name	Oncology
topics[0].display_name	Cytokine Signaling Pathways and Interactions
topics[1].id	https://openalex.org/T10755
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9724000096321106
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	HER2/EGFR in Cancer Research
topics[2].id	https://openalex.org/T10200
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9718000292778015
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2745
topics[2].subfield.display_name	Rheumatology
topics[2].display_name	Rheumatoid Arthritis Research and Therapies
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C71924100
concepts[0].level	0
concepts[0].score	0.9701815843582153
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[0].display_name	Medicine
concepts[1].id	https://openalex.org/C2777575956
concepts[1].level	2
concepts[1].score	0.8851199150085449
concepts[1].wikidata	https://www.wikidata.org/wiki/Q187255
concepts[1].display_name	Rheumatoid arthritis
concepts[2].id	https://openalex.org/C126322002
concepts[2].level	1
concepts[2].score	0.4515513479709625
concepts[2].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[2].display_name	Internal medicine
concepts[3].id	https://openalex.org/C2777077863
concepts[3].level	2
concepts[3].score	0.44660359621047974
concepts[3].wikidata	https://www.wikidata.org/wiki/Q170990
concepts[3].display_name	Arthritis
concepts[4].id	https://openalex.org/C203014093
concepts[4].level	1
concepts[4].score	0.43511682748794556
concepts[4].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[4].display_name	Immunology
concepts[5].id	https://openalex.org/C2777178219
concepts[5].level	3
concepts[5].score	0.4115332365036011
concepts[5].wikidata	https://www.wikidata.org/wiki/Q425154
concepts[5].display_name	Tocilizumab
keywords[0].id	https://openalex.org/keywords/medicine
keywords[0].score	0.9701815843582153
keywords[0].display_name	Medicine
keywords[1].id	https://openalex.org/keywords/rheumatoid-arthritis
keywords[1].score	0.8851199150085449
keywords[1].display_name	Rheumatoid arthritis
keywords[2].id	https://openalex.org/keywords/internal-medicine
keywords[2].score	0.4515513479709625
keywords[2].display_name	Internal medicine
keywords[3].id	https://openalex.org/keywords/arthritis
keywords[3].score	0.44660359621047974
keywords[3].display_name	Arthritis
keywords[4].id	https://openalex.org/keywords/immunology
keywords[4].score	0.43511682748794556
keywords[4].display_name	Immunology
keywords[5].id	https://openalex.org/keywords/tocilizumab
keywords[5].score	0.4115332365036011
keywords[5].display_name	Tocilizumab
language	en
locations[0].id	doi:10.1016/j.ard.2025.06.1600
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S25650217
locations[0].source.issn	0003-4967, 1468-2060
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0003-4967
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Annals of the Rheumatic Diseases
locations[0].source.host_organization	https://openalex.org/P4310319945
locations[0].source.host_organization_name	BMJ
locations[0].source.host_organization_lineage	https://openalex.org/P4310319945
locations[0].license	cc-by-nc-nd
locations[0].pdf_url
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-nc-nd
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Annals of the Rheumatic Diseases
locations[0].landing_page_url	https://doi.org/10.1016/j.ard.2025.06.1600
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5090924405
authorships[0].author.orcid
authorships[0].author.display_name	K. Mamoto
authorships[0].author_position	first
authorships[0].raw_author_name	K. Mamoto
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5056011991
authorships[1].author.orcid	https://orcid.org/0000-0002-8849-9824
authorships[1].author.display_name	Tadashi Okano
authorships[1].author_position	middle
authorships[1].raw_author_name	T. Okano
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5109869027
authorships[2].author.orcid
authorships[2].author.display_name	Y. Yamada
authorships[2].author_position	middle
authorships[2].raw_author_name	Y. Yamada
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5059137955
authorships[3].author.orcid	https://orcid.org/0000-0001-8497-0212
authorships[3].author.display_name	Toshihisa Kojima
authorships[3].author_position	middle
authorships[3].raw_author_name	T. Kojima
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5089728559
authorships[4].author.orcid	https://orcid.org/0000-0002-7439-0721
authorships[4].author.display_name	S. Anno
authorships[4].author_position	middle
authorships[4].raw_author_name	S. Anno
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5035005369
authorships[5].author.orcid	https://orcid.org/0000-0003-3291-2509
authorships[5].author.display_name	Kumi Orita
authorships[5].author_position	middle
authorships[5].raw_author_name	K. Orita
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5056802554
authorships[6].author.orcid	https://orcid.org/0000-0001-5028-2446
authorships[6].author.display_name	Tetsuo Iida
authorships[6].author_position	middle
authorships[6].raw_author_name	T. Iida
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5026023972
authorships[7].author.orcid
authorships[7].author.display_name	M. Tada
authorships[7].author_position	middle
authorships[7].raw_author_name	M. Tada
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5074232917
authorships[8].author.orcid	https://orcid.org/0000-0002-8747-7279
authorships[8].author.display_name	Kentaro Inui
authorships[8].author_position	middle
authorships[8].raw_author_name	K. Inui
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5074923100
authorships[9].author.orcid	https://orcid.org/0000-0002-1522-8740
authorships[9].author.display_name	Tatsuya Koike
authorships[9].author_position	middle
authorships[9].raw_author_name	T. Koike
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5024742369
authorships[10].author.orcid	https://orcid.org/0000-0001-9183-3363
authorships[10].author.display_name	Hidetomi Terai
authorships[10].author_position	last
authorships[10].raw_author_name	H. Terai
authorships[10].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1016/j.ard.2025.06.1600
open_access.oa_status	hybrid
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	ABS0812 COMPARISON OF THE CLINICAL EFFECTS OF JAK INHIBITORS AND IL-6 INHIBITORS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11503
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9894999861717224
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2730
primary_topic.subfield.display_name	Oncology
primary_topic.display_name	Cytokine Signaling Pathways and Interactions
related_works	https://openalex.org/W2093526042, https://openalex.org/W2275736852, https://openalex.org/W3096335653, https://openalex.org/W3136157950, https://openalex.org/W4366832216, https://openalex.org/W4285141748, https://openalex.org/W2978732689, https://openalex.org/W4285138557, https://openalex.org/W2883505650, https://openalex.org/W4231545279
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1016/j.ard.2025.06.1600
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S25650217
best_oa_location.source.issn	0003-4967, 1468-2060
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	0003-4967
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Annals of the Rheumatic Diseases
best_oa_location.source.host_organization	https://openalex.org/P4310319945
best_oa_location.source.host_organization_name	BMJ
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310319945
best_oa_location.license	cc-by-nc-nd
best_oa_location.pdf_url
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-nc-nd
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Annals of the Rheumatic Diseases
best_oa_location.landing_page_url	https://doi.org/10.1016/j.ard.2025.06.1600
primary_location.id	doi:10.1016/j.ard.2025.06.1600
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S25650217
primary_location.source.issn	0003-4967, 1468-2060
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0003-4967
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Annals of the Rheumatic Diseases
primary_location.source.host_organization	https://openalex.org/P4310319945
primary_location.source.host_organization_name	BMJ
primary_location.source.host_organization_lineage	https://openalex.org/P4310319945
primary_location.license	cc-by-nc-nd
primary_location.pdf_url
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-nc-nd
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Annals of the Rheumatic Diseases
primary_location.landing_page_url	https://doi.org/10.1016/j.ard.2025.06.1600
publication_date	2025-06-01
publication_year	2025
referenced_works_count	0
abstract_inverted_index
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	11
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.550000011920929
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.34454883
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False